Protocol for the development of a Core Outcome Set (COS) for hemorrhoidal disease: an international Delphi study

Autor: R. R. van Tol, Jarno Melenhorst, Laurents P. S. Stassen, Stephanie O. Breukink, Carmen D. Dirksen

Publikováno v: International Journal of Colorectal Disease
International Journal of Colorectal Disease, 32(7), 1091-1094. Springer, Cham

Purpose Over the last decade, many studies were performed regarding treatment options for hemorrhoidal disease. Randomised controlled trials (RCTs) should have well-defined primary and secondary outcomes. However, the reported outcome measures are nu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803e993279965f69872b0bcf92c51e81
http://europepmc.org/articles/PMC5486628

Short chain fatty acids in human gut and metabolic health.

Autor: Blaak EE; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands., Canfora EE; Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands., Theis S; Südzucker Group - Beneo, Wormser Str. 11, Mannheim, 67283, Germany., Frost G; Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, SW7 2AZ London, United Kingdom., Groen AK; Diabetes Center, Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.; Quantitative Systems Biology, Department of Pediatrics, Centre for Liver, Digestive and Metabolic Diseases, University Medical Centre Groningen (UMCG), University of Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands., Mithieux G; INSERM U1213, Faculté de Médecine Laennec, University of Lyon, 7-11 Rue Guillaume Paradin, 69372 Lyon, France., Nauta A; FrieslandCampina, P.O. Box 1551, 3800 BN Amersfoort, the Netherlands., Scott K; The Rowett Institute, University of Aberdeen, Aberdeen, AB25 2ZD, United Kingdom., Stahl B; Danone Nutricia Research, Uppsalalaan 12, 3584 CT, Utrecht, the Netherlands.; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands., van Harsselaar J; Südzucker Group - Beneo, Wormser Str. 11, Mannheim, 67283, Germany., van Tol R; Reckitt Benckiser/Mead Johnson Nutrition, Middenkampweg 2, 6545 CJ Nijmegen, the Netherlands., Vaughan EE; Sensus (Royal Cosun), Borchwerf 3, 4704 RG Roosendaal, the Netherlands., Verbeke K; Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Herestraat 49, 3000 Leuven, Belgium.

Publikováno v: Beneficial microbes [Benef Microbes] 2020 Sep 01; Vol. 11 (5), pp. 411-455. Date of Electronic Publication: 2020 Aug 31.

Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies.

Autor: Janssen JT, Ludwig H, Scheithauer W, de Pauw BE, Keyser A, van Tol R, Flener R

Publikováno v: Oncology [Oncology] 1985; Vol. 42 Suppl 1, pp. 3-6.